Pharmaceutical

Vertex secures CHMP nod for Casgevy approval in Europe

Following US and UK approvals, the EMA’s CHMP has recommended conditional approval for Casgevy, with a decision expected in Q1 2024.

Dec 18, 2023 - 10:51
Vertex secures CHMP nod for Casgevy approval in Europe
Following US and UK approvals, the EMA’s CHMP has recommended conditional approval for Casgevy, with a decision expected in Q1 2024.
Read the original article

Tags:

Previous Article

Novo Nordisk Foundation sets up airborne infection vaccine initiative

Next Article

Biocytogen and Ona enter cancer ADC development deal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FDA oncology head wants advisory panels to keep voting on new drugs

STAT+: FDA oncology head wants advisory panels to keep ...

Jun 6, 2023

FDA issues draft guidance on stimulant use disorder drug development

FDA issues draft guidance on stimulant use disorder dru...

Oct 5, 2023

NYBC rolls out $50m fund to advance blood and cellular therapy innovations

NYBC rolls out $50m fund to advance blood and cellular ...

May 12, 2023